Abstract:In recent years, immunotherapy has made significant progress in cancer treatment, especially in malignant tumors that are difficult to cure with traditional therapies, showing unprecedented potential 1 . However, many patients do not exhibit durable responses to immunotherapy in clinical practice, and the issue of drug resistance remains prominent, making immune cell exhaustion one of the main barriers to current cancer immunotherapy 2 . Immune cell exhaustion is a complex process involving prolonged antigen stimulation, activation of immunosuppressive signals, and cellular metabolic dysregulation, ultimately leading to the dysfunction of effector T cells and other immune cells, thereby weakening the anti-tumor immune response

Editorial: Immune cell exhaustion: new challenges and opportunities in cancer therapy